Autoimmune Hepatitis
Autoimmune Hepatitis is a chronic autoimmune disease where the body's immune system attacks liver cells, leading to inflammation, swelling, and liver damage, with symptoms like fatigue, abdominal pain, jaundice, and joint swelling. It often has no initial symptoms and is detected through abnormal liver function tests or protein levels during routine bloodwork.
Health Outcomes
- Achieved Histological Remission
- Adjusted Immune Function
- Aggravated Liver Injury
- Alleviated Autoimmune Hepatitis Symptoms
- Alleviated Liver Injury
- Altered Immune Response
- Attenuated Hepatic Disorders
- Changed Albumin Level
- Changes in Liver Fibrosis Markers
- Elevated Hepatic Enzyme Levels
- Elevated Plasma Immunoglobulin M Levels
- Elevated Serum Aspartate Aminotransferase Levels
- Elevated Serum Enzyme Levels
- Elevated Serum Globulin Levels
- Elevated Serum IgG2 Levels
- Enhanced Active Metabolite Levels
- Enhanced Immune Response Regulation
- Enhanced Liver Protection
- Enhanced T- and B-Lymphocyte Proliferation
- Improved Child-Pugh Score
- Improved Complement C3 Level
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Function
- Improved Immune Cell Function
- Improved Immunomodulation
- Improved Liver Biomarkers
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Activity
- Improved Liver Enzyme Function
- Improved Liver Function
- Improved Liver Health
- Improved Liver Histology
- Improved Liver Morphology
- Improved Liver Regeneration
- Improved Organ Histology
- Increased Activation of Regulatory T Cells
- Increased Antibody Production
- Increased Apoptosis of OVA-specific TCR Tg T Cells
- Increased Aspartate Aminotransferase Level
- Increased Aspartate Transferase Level
- Increased Bile Resistance
- Increased CD8 Percentage
- Increased Complement C4 Level
- Increased Hepatic Antioxidant Enzyme Levels
- Increased Liver Enzyme Levels
- Increased PT/INR
- Increased Plasma GLDH
- Increased Regulatory T Cell Frequency
- Increased Regulatory T Cell Induction
- Increased Regulatory T Cell Populations
- Increased Serum Immunoglobulins
- Increased Serum Peroxidase Activity
- Increased Serum Total Protein Levels
- Increased Specific Antibody Production
- Increased Splenic Lymphocyte Proliferation
- Increased Systemic Antibody Production
- Induced Immunomodulatory Effects
- Liver Histopathological Damage
- Lowered Serum Levels of Liver Injury Markers
- Maintained Normal ALT Levels
- Maintained Normal Liver Function
- Maintained Safety with Repeated Oral Exposure
- Modified Hepatic Inflammatory Cell Pattern
- Modulated Host Immune Response
- Modulated Immune Markers
- Modulated Immune Response
- Modulated Immunological Profile
- No Change in Fibrosis
- No Effect on Growth Parameters
- Normalized Serum IgA Levels
- Preserved Liver Function
- Preserved Liver Structure
- Prevented Liver Injury
- Prevented Liver Pathway Dysregulation
- Prevention of Autoimmune Disorders
- Prolonged INR
- Reduced ALT Levels
- Reduced Abnormal Increase in Bilirubin
- Reduced Acute Liver Injury
- Reduced Alanine Transaminase Levels
- Reduced Aminotransferase Levels
- Reduced Bile Acid Levels
- Reduced Blood Ammonia Level
- Reduced Dimethyl Sulfide Level
- Reduced Elevated Liver Enzymes
- Reduced Elevated Serum Alanine Aminotransferase (ALT)
- Reduced Fibrinogen Level
- Reduced GPT Level
- Reduced Globulin Level
- Reduced Hepatic Apoptosis
- Reduced Hepatic Damage Indices
- Reduced Hepatic Encephalopathy
- Reduced Hepatic Histological Injury
- Reduced Hepatic Inflammation
- Reduced Hepatic Inflammation Markers
- Reduced Hepatic Inflammation and Oxidative Stress
- Reduced Hepatic Inflammatory Cytokines
- Reduced Hepatic Steatosis Severity
- Reduced Hepatocellular Damage
- Reduced Hepatocyte Necrosis
- Reduced Hepatotoxicity
- Reduced Immune-Mediated Pathologies
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Liver Damage
- Reduced Liver Damage Indicators
- Reduced Liver Damage Markers Levels
- Reduced Liver Disease Progression
- Reduced Liver Disease Symptoms
- Reduced Liver Enzyme Activity
- Reduced Liver Fibrosis
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Inflammation
- Reduced Liver Inflammation Fibrosis Score
- Reduced Liver Injury
- Reduced Liver Injury Indicators
- Reduced Liver Injury Marker
- Reduced Liver Oxidative Damage
- Reduced Liver Stiffness
- Reduced Liver Toxicity
- Reduced Lobular Inflammation
- Reduced Pathological Changes of Liver
- Reduced Pro-Inflammatory Fatty Acids
- Reduced Procollagen Type 1 N-terminal Propeptide Level
- Reduced Serum Alanine Aminotransferase Activity
- Reduced Serum Alanine Aminotransferase Levels
- Reduced Serum Gamma Glutamine Transaminase Levels
- Reduced Serum Transaminase Levels
- Reduced Urea Level
- Regulated Liver Immune Homeostasis
- Regulated Liver Metabolite Levels
- Regulated Systemic Immune Response Imbalance
- Significant Histopathological Changes in Liver
- Stabilized Total Bilirubin Levels
- Stable Alanine Aminotransferase Levels
- Stable Aspartate Aminotransferase Levels